Objectives-To estimate women's expectations of the accuracy of screening mammography and to explore attitudes towards compensation for missed cancers.
Screening mammography is provided for women aged about 50 to 70 years in many countries including the United Kingdom, USA and Australia. Estimates of the sensitivity of screening mammography vary from study to study and according to age but generally lie in the range 75% to 95%. 1 2 There is evidence that women are not well informed about the accuracy of screening mammography and may not be aware of the false negative rate (1− sensitivity). A recent survey of 58 pamphlets about mammographic screening in Australia found that information about the accuracy of screening mammography was provided only occasionally, with a quarter of pamphlets giving information about sensitivity and none giving information about specificity. 3 Earlier work showed that 35% of women thought that screening mammography would detect breast cancer in 95-100% of cases. 4 Some authors have speculated that this ignorance contributes to a sense of anger and betrayal if a cancer is missed, which may make women more likely to sue for negligence and financial compensation. 5 Women have already successfully sued for false negative results in the context of diagnostic tests (that is, tests applied to symptomatic women) in Australia. For example, in 1994 an Australian woman successfully sued a pathology laboratory for the delay in diagnosing her cancer of the cervix after a negative Pap smear, taken to investigate irregular vaginal bleeding. 6 To the best of our knowledge no one has successfully sued for negligence over a false negative result of a screening test in Australia although it is impossible to determine what cases may have been settled out of court. Therefore it remains unclear whether a similar outcome may be achieved in the screening context. It has been argued that successful claims against a screening programme could render the breast and cervical screening programmes in Australia unsustainable because of increasing costs and increasing overdetection and overtreatment of minor abnormalities. 7 8 Similar concerns have been expressed in the UK 9 10 and the USA. 11 It has been suggested that public education emphasising that screening tests are not, even at the highest levels of practice, 100% accurate may be helpful. 5 8 9 11 Methods We used the 1996 National Breast Health Survey (undertaken by the National Health and Medical Research Council's National Breast Cancer Centre) to undertake some exploratory work on women's expectations about the accuracy of screening mammography and their attitudes towards legal action and financial compensation for missed cancers. A detailed description of the survey has been published.
Briefly, the Breast Health Survey was conducted nationally by telephone by a market research company on behalf of the National Breast Cancer Centre (NBCC) in April 1996 to estimate current knowledge and behaviour in relation to breast cancer and early detection practices. A simple random sample of 3000 women aged 30-69 years was used with stratification by State and by area of residence (urban and rural).
A random sample (n=115) of all respondents to the Breast Health Survey were asked an extra set of questions about medicolegal aspects of diagnosis, the results of which are reported in this paper. The medicolegal questions were developed specifically for this work; they were based on previous work by Cockburn et al 4 and were qualitatively pilot tested with 20 volunteers, revised and pilot tested again with a further 100 volunteers before the main survey. Only 115 women were asked these additional questions as we estimated that 95% confidence limits of approximately +/-10% would be adequately precise and because it was not considered feasible to ask all women to spend the extra 20 minutes that was required to answer these questions.
VALIDATION OF THE SURVEY
To assess potential selection bias we obtained data from February 1996 Australian Bureau of Statistics (ABS) Population Survey Monitor, which is conducted quarterly by household interview for the Commonwealth Government to supplement census data. In addition we placed one of our questions, "Have you ever had a mammogram?", into the ABS survey. The question was asked only of women 30-69 years in the ABS survey to provide a result comparable with our study.
STATISTICAL METHODS
SPSS statistical package was used for all analyses. We calculated 95% confidence intervals for important proportions. Where it was necessary to compare means, a t test for independent samples was used and diVerences in proportions were compared using the 2 statistic. Logistic regression using backwards stepwise elimination of variables was used to model the predictors of favouring financial compensation. We calculated 95% confidence intervals around the coeYcient estimates and exponentiated to give the confidence intervals around the estimated odds ratios.
Results

RESPONDENT CHARACTERISTICS AND RESPONSE
RATE
The raw response rate (completed interviews over contacted eligible women) was 70.2%; the adjusted response rate (adjusting for eligible women among those who could not be contacted) was 64.4%. The results reported here are based on responses from 115 women who were chosen at random from the total sample of 2935 women to complete extra questions on medicolegal issues. These women were similar to the total group in sociodemographic characteristics (table 1); for example the mean age of the subset of 115 women was 46.38 years compared with 46.35 years for the whole group (t=0.036, p=0.972) and there were no diVerences in the proportions of women living in urban and rural/ remote areas ( 2 = 1.077, p=0.30). The women in both the total survey group and the subset reported here were similar to Australian national data as measured by the Australian Bureau of Statistics (table 1) . 13 Approximately half the women (57.4%) had ever had a mammogram, which is close to the national average of 50% (table 1). PERCEIVED SENSITIVITY OF SCREENING MAMMOGRAPHY Women were asked: "Imagine a situation where 100 women really have early breast cancer but the cancer is as yet undetected. Along with many other women they all have a screening mammogram (to detect breast cancer before any symptoms, like a lump, are present). On average, how many of the 100 women do you think the mammogram would pick up?" The meaning of each woman's response was checked by asking "So that means that it would pick up ...% of the cancers and miss ...% is that right?" in an iterative fashion until the respondent and the interviewer agreed upon the percentage picked up.
In subsequent questions, women were asked ".... realistically how many of these 100 women do you think the test should pick up?" and "Of the 100 women who actually have breast cancer, what would you say would be the absolute minimum number that the screening mammogram should detect to be called a worthwhile test?" Table 2 gives the responses to these questions.
There was substantial variation in women's estimates of the sensitivity of screening mammography; only 35% (34.8%, 95%CI 26.1, 43.5) reported it to be in the range of 80-94%, which is correct allowing for the known variation in sensitivity by age. However, about one third (32.2%, 95% CI 23.7, 40.7) had unrealistically high expectations of the sensitivity, reporting it to be over 95%.
Almost half the women (43.5%, 95%CI 34.4, 52.7) thought that screening mammography "realistically should" pick up all cancers (that is, should be 100%), and three quarters of the women (77.4%, 95%CI 69.8, 85.0) reported that the sensitivity should be over 90%.
Nevertheless, women were prepared to accept much lower sensitivities before deciding that screening would not be worthwhile. Only 14% of women (13.9, 95%CI 7.6, 20.2) said 100% of cancers should be detected for screening to be worthwhile. About half the women (52.1%, 43.0, 61.2) reported screening would be worthwhile if sensitivity was 90% or better.
PROPORTION OF WOMEN FAVOURING COMPENSATION FOR A BREAST CANCER MISSED BY
SCREENING
Women were asked "A woman who has undetected early breast cancer is invited to have a screening mammogram. Due to the small error rate of the test the cancer is not picked up at this stage. The cancer is detected only at a later stage by a separate test. Do you think this woman should receive compensation?" Subsequently women were asked a similar question but in a situation where the cancer was not detected because someone involved in performing the test made a negligent error, for instance did not pass on an abnormal result.
Forty five per cent of women (45.2%, 95%CI 36.10, 54.3) were in favour of financial compensation being awarded if the breast cancer was missed because of the failure rate of the screening test. However, if the cancer was missed because of a negligent error made by someone in the screening process, 93% (95%CI 88.3, 97.7) of women thought compensation should be awarded.
PREDICTORS OF FAVOURING COMPENSATION FOR A BREAST CANCER MISSED BY SCREENING (BECAUSE OF THE FAILURE RATE OF THE TEST)
In the main survey women were asked questions about breast cancer incidence and about their perceived likelihood of getting breast cancer. 13 From the responses to these questions variables were constructed to represent women's knowledge about breast cancer (based on whether she could accurately report the breast cancer incidence in Australia) and her perceived risk as either low to average (<12%) or high (>12%). In addition a variable based on whether women were realistic or unrealistic in their beliefs about the sensitivity of screening mammography was constructed from the data presented in table 2. Women who thought that the sensitivity of screening mammography is 95% or greater were classified as unrealistic.
The major sociodemographic factors (age, education, and area of residence) plus the developed variables outlined above, were tested in the logistic regression model because it was thought a priori that these variables might influence women's views and univariate analysis supported this. A personal history of mammography was not associated with favouring compensation in univariate analysis (women were just as likely to favour compensation whether they had had a mammogram or not, ( 2 = 0.21, p=0.88) so this variable was not entered into the model. Significant predictors of favouring financial compensation even if the delay was attributable to the error rate of the test were younger age, residence in an urban rather than a rural area, a realistic perception of the accuracy of screening mammography and a perception that one's own risk of breast cancer is about population average or less ( Most women said there was no alternative to taking legal action (6%) or were unable to answer this question (63%). However, a few alternatives were oVered that primarily related to some form of financial assistance or out of court payment to cover medical costs and family expenses (10%) or the provision of counselling services (5%).
Discussion
Although our sample was small, there is little evidence of selection bias as there were no important sociodemographic diVerences between the subset of women whose results are presented here, our total survey population (n=2935) and the Australian population as measured by the Australian Bureau of Statistics 13 (table 1) . Women have been shown to overestimate both their chances of getting breast cancer and the eVectiveness of screening in reducing breast cancer mortality.
14 This study provides evidence that women also overestimate the accuracy of mammographic screening and is consistent with the earlier study by Cockburn et al. 4 Furthermore, we found that almost half the women thought that screening mammography "realistically should" pick up all cancers (that is, should be 100%). The previous study was done in 1994, which suggests that public knowledge about screening mammography has not improved and expectations of accuracy are still high. This is not surprising given the enthusiastic way in which mammographic screening has been promoted, often with limited acknowledgement of the potential for both false negative and false positive results. 3 15 Unfortunately we did not collect any information on the perceived specificity of mammographic screening. This should be investigated because it seems likely that many women may also be unaware of the likelihood of a false positive result and its potential consequences.
This study suggests that most women in Australia think that compensation should be awarded in cases where there is negligence on the part of one or more health professionals leading to a delayed diagnosis. Fewer, but still about half of surveyed women, thought financial compensation should be awarded for missed cancers even if the cancer was missed because of the error rate of the test and not because of negligence. Many women nominated financial needs as the primary motivation for seeking compensation, which suggests that a system of no fault compensation for false negative reports, similar to systems of compensation for adverse eVects after immunisation, might be helpful.
False negative results may occur for several reasons. Firstly, the cancer may have arisen after the mammogram, that is it may be an interval cancer that presents clinically before the next screen is due. Alternatively the cancer may have been present at the time of the mammogram but was missed either through negligent or non-negligent error. Resolving these distinctions may prove diYcult in the courts as the issues are even more complex than they are around errors in diagnostic tests. In the case referred to earlier 6 the judge determined that the interpretation of the smear made by the pathology company could not be explained as an acceptable diVerent interpretation. Therefore the only explanation was that the interpretation was wrong and the error was made negligently. The decision as to whether a false negative report from a screening test is negligent rests with the judge hearing the case and presumably the decision will be made along the same lines. Currently therefore the outcome of such a case is unpredictable. This uncertainty has led to calls for statutory immunity from suit for providers of screening services who comply with certain standards of care as laid down by an appropriate accrediting agency. 16 Information about both the false negative and false positive rate of screening tests should be provided so that people are better able to make an informed choice about participation in screening. In addition, it needs to be clear that a negative result does not completely exclude disease and tells nothing about whether disease will develop in the future.
Although it is intuitively appealing to think that if women have realistic information about the accuracy of mammographic screening they will be less inclined to seek financial compensation for missed cancers, this may not be the case. The results of this study suggest that as women's knowledge about the true accuracy of screening mammography increases we might expect that more women may seek financial compensation for missed cancers.
In conclusion, many women have unrealistically high expectations of the sensitivity of screening for breast cancer. About half of women favoured financial compensation for missed cancers even if the cancer was missed solely because of the failure rate of the test. Predictors of favouring compensation included young age and realistic expectations of the accuracy of tests. Consideration needs to be given to the legal status of non-negligent false results and alternative ways of compensating women whose cancers are missed. Public education is required to inform women of the accuracy of mammographic screening but this may not modify the widely held view that compensation should be sought when cancers are missed. 
